What is the discontinuation rate for semaglutide due to side effects
J Pharmacol Sci 95:1926 Prkacin I, Separovic J, Aralicia G, Perovic D, Gjurasin M, Lovric-Bencic M, Stancic-Rokotov D, Staresinic M, Anic T, Mikus D et al (2001) Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine
It is an experimental research tool, not a magic cure
BPC 157 is classified as a healing peptide
Methods 70 SapplP
Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about eloralintide as a potential treatment for adults with obesity or overweight, and the timeline for future clinical studies, presentations, and other milestones relating to eloralintide and its clinical trials and reflects Lilly's current beliefs and expectations
